SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-018625
Filing Date
2016-08-05
Accepted
2016-08-05 17:05:00
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q q2201610q.htm 10-Q 688213
2 EXHIBIT 31.1 q22016-exhibit311.htm EX-31.1 16027
3 EXHIBIT 31.2 q22016-exhibit312.htm EX-31.2 16036
4 EXHIBIT 32.1 q22016-exhibit321.htm EX-32.1 8331
  Complete submission text file 0001628280-16-018625.txt   2637303

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20160630.xml EX-101.INS 392612
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20160630.xsd EX-101.SCH 23138
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20160630_cal.xml EX-101.CAL 48390
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20160630_def.xml EX-101.DEF 61360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20160630_lab.xml EX-101.LAB 288115
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20160630_pre.xml EX-101.PRE 155136
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 161811918
SIC: 2834 Pharmaceutical Preparations